BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • David C. Smith, M.D., FACP
    Professor of Internal Medicine and Professor of Urology
    University of  Michigan School of Medicine

    Dr. Smith is Professor of Internal Medicine and Professor of Urology at the University of Michigan School of Medicine and a member of the University of Michigan Comprehensive Cancer Center. He is an active member of the Genitourinary Committee of the Southwest Oncology Group and is a member of the American Association for Cancer Research and the American Society of Clinical Oncology where he has served on the Scientific Program Committee. Dr. Smith is the author or coauthor of over 50 publications focusing on the conduct of clinical trials aimed at the development of novel therapies for the treatment of genitourinary malignancies.

    Since 2003 Dr. Smith has served as the Medical Director of the University of Michigan Comprehensive Cancer Center Clinical Trials Office and he has recently been appointed as the co-Director of the Phase I Program at the UMCCC. Dr. Smith received his medical degree and residency training at the University of Washington in Seattle, and completed his fellowship training in Hematology and Medical Oncology at Duke University. He has been a faculty member at the University of Michigan since 1995.
    Click here for more information about Dr. Smith.